Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,738031,Alc14,Alcohol consumption QTL 14,7.6,0.00003,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,59948935,154902892,Rat,n/a,region,qtl 1000,738016,Alc16,Alcohol consumption QTL 16,3.6,0.00015,consumption behavior trait (VT:0002069),ethanol drink intake rate to body weight ratio (CMO:0001616),4,59948935,154902892,Rat,n/a,region,qtl 1000,70200,Alc18,Alcohol consumption QTL 18,9.2,,drinking behavior trait (VT:0001422),ethanol intake volume to total fluid intake volume ratio (CMO:0001591),4,56647873,149491524,Rat,n/a,region,qtl 1000,634335,Anxrr16,Anxiety related response QTL 16,7.22,,locomotor behavior trait (VT:0001392),number of entries into a discrete space in an experimental apparatus (CMO:0000960),4,93308457,167139447,Rat,n/a,region,qtl 1000,6478693,Anxrr32,Anxiety related response QTL 32,,0.00092,locomotor behavior trait (VT:0001392),"measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)",4,144639524,182687754,Rat,n/a,region,qtl 1000,6478700,Anxrr33,Anxiety related response QTL 33,,0.00896,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,144639524,182687754,Rat,n/a,region,qtl 1000,6478718,Anxrr34,Anxiety related response QTL 34,,0.00896,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,144639524,182687754,Rat,n/a,region,qtl 1000,6478748,Anxrr42,Anxiety related response QTL 42,,0.28008,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,144639524,182687754,Rat,n/a,region,qtl 1000,6478754,Anxrr43,Anxiety related response QTL 43,,0.14035,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,144639524,182687754,Rat,n/a,region,qtl 1000,6478760,Anxrr45,Anxiety related response QTL 45,,0.06717,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110870972,155870972,Rat,n/a,region,qtl 1000,6478763,Anxrr46,Anxiety related response QTL 46,,0.07428,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,110870972,155870972,Rat,n/a,region,qtl 1000,6478778,Anxrr51,Anxiety related response QTL 51,,0.25384,locomotor behavior trait (VT:0001392),"measurement of voluntary locomotion into, out of or within a discrete space in an experimental apparatus (CMO:0000957)",4,124778595,169778595,Rat,n/a,region,qtl 1000,12798519,Anxrr54,Anxiety related response QTL 54,2.54,0.05,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,114627026,159627026,Rat,n/a,region,qtl 1000,12798523,Anxrr56,Anxiety related response QTL 56,2.83,0.05,locomotor behavior trait (VT:0001392),amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958),4,85253748,150276390,Rat,n/a,region,qtl 1000,12798527,Anxrr58,Anxiety related response QTL 58,4.11,0.05,locomotor behavior trait (VT:0001392),"distance moved per unit of time into, out of or within a discrete space in an experimental apparatus (CMO:0001493)",4,119463257,147278687,Rat,n/a,region,qtl 1000,1578674,Bmd12,Bone mineral density QTL 12,3.8,,femur mineral mass (VT:0010011),cortical volumetric bone mineral density (CMO:0001730),4,135699135,180699135,Rat,n/a,region,qtl 1000,2293659,Bmd35,Bone mineral density QTL 35,4.5,0.0001,femur strength trait (VT:0010010),femoral neck ultimate force (CMO:0001703),4,137755016,181392681,Rat,n/a,region,qtl 1000,631683,Bp116,Blood pressure QTL 116,,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),4,124303370,169303370,Rat,n/a,region,qtl 1000,1331738,Bp209,Blood pressure QTL 209,2.979,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),4,138503169,179293946,Rat,n/a,region,qtl 1000,7207480,Bss105,Bone structure and strength QTL 105,8.1,,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),4,109827074,154827074,Rat,n/a,region,qtl 1000,1549832,Bss3,Bone structure and strength QTL 3,11,,femur morphology trait (VT:0000559),femur midshaft cortical cross-sectional area (CMO:0001663),4,109827074,154827074,Rat,n/a,region,qtl 1000,7411558,Bw133,Body weight QTL 133,13.84,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),4,125590636,170590636,Rat,n/a,region,qtl 1000,61422,Cia13,Collagen induced arthritis QTL 13,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,132642577,167139601,Rat,n/a,region,qtl 1000,634342,Cia24,Collagen induced arthritis QTL 24,4.5,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,146565735,175236377,Rat,n/a,region,qtl 1000,61434,Cia3,Collagen induced arthritis QTL 3,4.8,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,103194656,148194656,Rat,n/a,region,qtl 1000,61451,Ciaa4,CIA Autoantibody QTL 4,3.1,,blood autoantibody amount (VT:0003725),calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281),4,126395976,167139601,Rat,n/a,region,qtl 1000,724535,Cm18,Cardiac mass QTL 18,2.6,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),4,118856416,163856416,Rat,n/a,region,qtl 1000,1576305,Emca6,Estrogen-induced mammary cancer QTL 6,5.8,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),4,44463720,155883716,Rat,n/a,region,qtl 1000,1576316,Ept5,Estrogen-induced pituitary tumorigenesis QTL 5,3.8,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),4,83428419,177635233,Rat,n/a,region,qtl 1000,1354612,Foco1,Food consumption QTL 1,8.87,,eating behavior trait (VT:0001431),food intake rate (CMO:0000427),4,44463908,148090542,Rat,n/a,region,qtl 1000,70201,Gcr1,Gastric cancer resistance QTL 1,2.7,,stomach morphology trait (VT:0000470),stomach tumor susceptibility score (CMO:0002043),4,120260281,147278687,Rat,n/a,region,qtl 1000,1358202,Gluco11,Glucose level QTL 11,2.4,0.02,adipocyte glucose uptake trait (VT:0004185),absolute change in adipocyte glucose uptake (CMO:0000873),4,85379421,167139601,Rat,n/a,region,qtl 1000,1582232,Gluco25,Glucose level QTL 25,3.6,0.0023,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,85253748,148090731,Rat,n/a,region,qtl 1000,2316958,Gluco58,Glucose level QTL 58,10,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),4,11320076,180699135,Rat,n/a,region,qtl 1000,634347,Hcar8,Hepatocarcinoma resistance QTL 8,5.8,,liver integrity trait (VT:0010547),liver tumorous lesion area to total liver area ratio (CMO:0001075),4,123143783,168143783,Rat,n/a,region,qtl 1000,737821,Hcar9,Hepatocarcinoma resistance QTL 9,3.7,,liver integrity trait (VT:0010547),volume of individual liver tumorous lesion (CMO:0001078),4,109866907,167139601,Rat,n/a,region,qtl 1000,1331759,Hrtrt13,Heart rate QTL 13,3.54628,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,110275411,168266883,Rat,n/a,region,qtl 1000,1300116,Hrtrt5,Heart rate QTL 5,3.76,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),4,116179486,151161268,Rat,n/a,region,qtl 1000,631674,Iddm14,Insulin dependent diabetes mellitus QTL 14,,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),4,64528739,157573521,Rat,n/a,region,qtl 1000,2293840,Kiddil9,Kidney dilation QTL 9,2.9,,kidney pelvis morphology trait (VT:0004194),hydronephrosis severity score (CMO:0001208),4,120926564,148090731,Rat,n/a,region,qtl 1000,10401796,Kidm48,Kidney mass QTL 48,,,kidney mass (VT:0002707),both kidneys wet weight (CMO:0000085),4,145568712,182687754,Rat,n/a,region,qtl 1000,61362,Oia2,Oil induced arthritis QTL 2,,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,138503169,173369699,Rat,n/a,region,qtl 1000,1298524,Oia8,Oil induced arthritis QTL 8,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,138503169,173369699,Rat,n/a,region,qtl 1000,737978,Pia23,Pristane induced arthritis QTL 23,5.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,131730738,167139601,Rat,n/a,region,qtl 1000,2302049,Pia32,Pristane induced arthritis QTL 32,5.1,0.001,blood autoantibody amount (VT:0003725),serum immunoglobulin G-type rheumatoid factor level relative to an arbitrary reference serum (CMO:0002112),4,105789505,150789505,Rat,n/a,region,qtl 1000,631511,Pia7,Pristane induced arthritis QTL 7,4.3,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),4,131730738,167139601,Rat,n/a,region,qtl 1000,724558,Plsm2,Polydactyly-luxate syndrome (PLS) morphotypes QTL 2,,0.0003,hindlimb integrity trait (VT:0010563),hind foot phalanges count (CMO:0001949),4,132422778,177422778,Rat,n/a,region,qtl 1000,738009,Sach4,Saccharine consumption QTL 4,4.9,0.000016,consumption behavior trait (VT:0002069),saccharin intake volume to total fluid intake volume ratio (CMO:0001601),4,59948935,154902892,Rat,n/a,region,qtl 1000,1354660,Salc1,Saline consumption QTL 1,11.26,,drinking behavior trait (VT:0001422),saline drink intake rate (CMO:0001627),4,44463908,148090542,Rat,n/a,region,qtl 1000,1549827,Scl46,Serum cholesterol level QTL 46,3.5,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),4,132396220,177396220,Rat,n/a,region,qtl 1000,61406,Scwia1,Streptococcal cell wall induced arthritis QTL 1,2.3,,joint integrity trait (VT:0010548),experimental arthritis severity measurement (CMO:0001459),4,106805662,151805662,Rat,n/a,region,qtl 1000,1331802,Srn5,Serum renin concentration QTL 5,3.045,,renin activity (VT:0005581),plasma renin activity level (CMO:0000116),4,119428175,157578333,Rat,n/a,region,qtl 1000,731165,Uae21,Urinary albumin excretion QTL 21,2.4,0.0001,urine albumin amount (VT:0002871),urine albumin excretion rate (CMO:0000757),4,106649412,151649412,Rat,n/a,region,qtl 1000,2303623,Vencon2,Ventilatory control QTL 2,3.8,,respiration trait (VT:0001943),minute ventilation (CMO:0000132),4,135204660,180204660,Rat,n/a,region,qtl 1000,70177,Xhs1,X-ray hypersensitivity QTL 1,25.1,,intestine integrity trait (VT:0010554),post-insult time to onset of moribundity (CMO:0001896),4,82798864,152731274,Rat,n/a,region,qtl